Smith & Nephew (BSP:S1NN34) FFO


BSP:S1NN34 Smith & Nephew PLC BSP:S1NN34
86 GF Score
Price R$33.81
GF Value R$35.85
! 3 Warning Signs
View Full Analysis

What is Smith & Nephew FFO?

FFO (Funds from operations) only applies to REITs.

BSP:S1NN34
86GF Score
Smith & Nephew PLC BSP:S1NN34
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Smith & Nephew (BSP:S1NN34) Overvalued in 2026?

Based on GuruFocus' analysis, Smith & Nephew stock appears to be undervalued. The current stock price of R$33.81 is trading 5.7% below its estimated GF Value™ of R$35.85.

Key valuation signals for BSP:S1NN34:

  • FFO:
  • GF Value™: R$35.85 vs. price of R$33.81 (5.7% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the BSP:S1NN34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Smith & Nephew Business Description

Address Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
86GF Score

Get the complete analysis for BSP:S1NN34

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$33.81
Price
R$35.85
GF Value